Manby Frederick Rinsider trades

In SEC Form 4 filings, Manby Frederick R is listed as Chief Technology Officer of Iambic Therapeutics, Inc. (IAM). Manby Frederick R reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.

Companies and roles

Company	Role	Transactions	Last filed
IAMIambic Therapeutics, Inc.	Chief Technology Officer	2	Oct 16

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-16

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
IAMIambic Therapeutics, Inc.	Oct 14	Oct 16	A	132,200	$0.00	$0	1,862,665	No	Form 4
IAMIambic Therapeutics, Inc.	Oct 14	Oct 16	A · derivative	793,200	$16.00	$12,691,200	793,200	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.